Vossius, G.; Meex, C.; Moerman, F.; Thys, M.; Ernst, M.; Bourgeois, M.-E.; Wagner, L.; Delahaye, T.; Darcis, G.
Clinical Outcomes of Third-Generation Cephalosporin Definitive Therapy for Bloodstream Infections Due to Enterobacterales with Potential AmpC Induction: A Single-Center Retrospective Study. Pathogens 2023, 12, 1152.
https://doi.org/10.3390/pathogens12091152
AMA Style
Vossius G, Meex C, Moerman F, Thys M, Ernst M, Bourgeois M-E, Wagner L, Delahaye T, Darcis G.
Clinical Outcomes of Third-Generation Cephalosporin Definitive Therapy for Bloodstream Infections Due to Enterobacterales with Potential AmpC Induction: A Single-Center Retrospective Study. Pathogens. 2023; 12(9):1152.
https://doi.org/10.3390/pathogens12091152
Chicago/Turabian Style
Vossius, Gilles, Cécile Meex, Filip Moerman, Marie Thys, Marie Ernst, Marie-Eve Bourgeois, Léa Wagner, Thibaut Delahaye, and Gilles Darcis.
2023. "Clinical Outcomes of Third-Generation Cephalosporin Definitive Therapy for Bloodstream Infections Due to Enterobacterales with Potential AmpC Induction: A Single-Center Retrospective Study" Pathogens 12, no. 9: 1152.
https://doi.org/10.3390/pathogens12091152
APA Style
Vossius, G., Meex, C., Moerman, F., Thys, M., Ernst, M., Bourgeois, M.-E., Wagner, L., Delahaye, T., & Darcis, G.
(2023). Clinical Outcomes of Third-Generation Cephalosporin Definitive Therapy for Bloodstream Infections Due to Enterobacterales with Potential AmpC Induction: A Single-Center Retrospective Study. Pathogens, 12(9), 1152.
https://doi.org/10.3390/pathogens12091152
